PubMed Health⌕ Search

PubMed · 15629010

Amorphous pharmaceutical solids.

Abstract

Amorphous forms are, by definition, non-crystalline materials which possess no long-range order. Their structure can be thought of as being similar to that of a frozen liquid with the thermal fluctuations present in a liquid frozen out, leaving only "static" structural disorder. The amorphous solids have always been an essential part of pharmaceutical research, but the current interest has been raised by two developments: a growing attention to pharmaceutical solids in general, especially polymorphs and solvates and a revived interest in the science of glasses and the glass transition. Amorphous substances may be formed both intentionally and unintentionally during normal pharmaceutical manufacturing operations. The properties of amorphous materials can be exploited to improve the performance of pharmaceutical dosage forms, but these properties can also give rise to unwanted effects that need to be understood and managed in order for the systems to perform as required.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Edina Vranić. 2004. Amorphous pharmaceutical solids.. https://doi.org/10.17305/bjbms.2004.3383

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The influence of water content of triglyceride oils on the solubility of steroids.

PURPOSE: To determine if hydration of long- and medium-chain triglyceride oils (long = soybean and olive, medium = Miglyol 812) has a significant effect on the ability to solubize the model hydrophobic compounds progesterone, estradiol, and testosterone. METHODS: Soybean, olive, and Miglyol 812 oils were treated in one of two ways: hydrated or desiccated (hydrated, then dried). Solubility of (3)H-labeled progesterone, estradiol, and testosterone in the triglycerides was measured by liquid scintillation counting. RESULTS: Both hydration state and chain length of the triglycerides were shown to have a significant influence on the solubility of steroids. Solubility of estradiol hemihydrate and testosterone monohydrate in hydrated triglycerides is decreased by about 30%-40% compared with desiccated oils. The solubility of anhydrous testosterone was decreased by hydration of the oils due to conversion to the monohydrate crystalline form. In contrast, the solubility of progesterone was insensitive to the state of hydration of all oils. CONCLUSIONS: Hydration of triglyceride oils caused a significant decrease in the solubility of steroids, which may form hydrates or hemihydrates. Results suggest the need for knowledge of the hydration state of triglyceride oils to be used as pharmaceutical excipients.

Chemistry, Pharmaceutical↗

Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.

PURPOSE: Manufacturing processes expose protein pharmaceuticals to organic solvents that may perturb the native folded state, increasing the potential for irreversible aggregation or surface adsorption. The aim of this study was to characterize the conformational states of human growth hormone (hGH) in aqueous ethanolic solutions. METHODS: The higher order structure of hGH was investigated using far- and near-UV circular dichroism (CD) and fluorescence spectroscopy as orthogonal techniques, and the hydrodynamic size was monitored using dynamic light scattering. RESULTS: CD data suggested that the secondary structure of hGH remained unchanged up to 50\% (v/v) ethanol, but the tertiary structure was perturbed at a20% ethanol. Fluorescence anisotropy, however, showed that the mobility of the buried Trp residue was restricted even at 30% ethanol, suggesting a differently packed structural core in 30% ethanol relative to the native structure. Consistent with this result, thermal unfolding of hGH in 30% ethanol was more facile compared to that in 0% and 20% ethanol. At >40% ethanol, fluorescence data were consistent with increased solvent exposure of the tryptophan. CONCLUSIONS: The results point to progressive unfolding of hGH that increases solvent exposure of the hydrophobic core as a function of ethanol concentration and suggest that non-native intermediate states are populated in 30-60% ethanol.

Chemistry, Pharmaceutical↗

Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.

The proven clinical efficacy of the CB(1) cannabinoid receptor antagonist rimonabant in both obesity and smoking cessation and its therapeutic potential in other disorders has given a tremendous impetus to the discovery of novel CB(1) antagonists. The number of disclosed patents wherein novel chemical entities having CB(1) antagonistic or inverse agonistic properties have been claimed has exploded. Besides novel compound classes that were identified in screening, rational medicinal chemistry approaches such as conformational constraint and scaffold hopping have been successfully applied. CB(1) receptor modelling has provided insight into crucial receptor-ligand interaction points thereby leading to a general CB(1) inverse agonist pharmacophore model.

Chemistry, Pharmaceutical↗